Rice G P, Finney D, Braheny S L, Knobler R L, Sipe J C, Oldstone M B
J Neuroimmunol. 1984 Apr;6(2):75-84. doi: 10.1016/0165-5728(84)90028-6.
Here we report our experience in profiling peripheral blood T-cell subsets with the monoclonal antibodies OKT4, OKT5 , and OKT8. Lymphocyte surface phenotype was measured by automated cytofluorometry. In a population survey, we were unable to detect differences between patients with multiple sclerosis (MS) and control subjects when we compared ratios of lymphocytes of helper cell phenotype (OKT4) to those with suppressor cell phenotype ( OKT5 and OKT8). No differences could be established between patients with stable disease, chronic progressive disease, or those with active disease. In a study of 10 patients followed through an exacerbation, we were also unable to define perturbations in these lymphocyte ratios that correlated with disease activity. Detailed analysis of the fluorescence histogram, which examines the entire spectrum of cell surface fluorescence intensity in a population of lymphocytes, was also not useful in predicting disease activity in these patients. The discrepancies between these data and other reports in the literature are discussed. We propose that these reagents are inadequate indices of disease activity, and that until other monoclonal reagents are developed and studied, the suppressor cell compartment is best assessed by assays of function.
在此,我们报告使用单克隆抗体OKT4、OKT5和OKT8对外周血T细胞亚群进行分析的经验。通过自动细胞荧光测定法测量淋巴细胞表面表型。在一项人群调查中,当我们比较辅助细胞表型(OKT4)的淋巴细胞与抑制细胞表型(OKT5和OKT8)的淋巴细胞比例时,未能检测到多发性硬化症(MS)患者与对照受试者之间的差异。病情稳定、慢性进展性疾病或活动性疾病患者之间也未发现差异。在一项对10例病情加重患者进行随访的研究中,我们也无法确定这些淋巴细胞比例的变化与疾病活动之间的关联。对荧光直方图的详细分析,该分析检查淋巴细胞群体中细胞表面荧光强度的整个光谱,在预测这些患者的疾病活动方面也没有帮助。讨论了这些数据与文献中其他报告之间的差异。我们认为这些试剂不是疾病活动的充分指标,并且在开发和研究其他单克隆试剂之前,抑制细胞亚群最好通过功能测定来评估。